EVALUATION OF THE IMPACT OF METABOLIC SYNDROME ON CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME
Abstract
Cardiovascular diseases (CVD) still remain the main cause of death in Uzbekistan [2]. Conducted clinical studies demonstrate the high prevalence of metabolic syndrome (MS) and its adverse effect on the course and prognosis of patients with acute coronary syndrome [3-9]. However, the results of studies on long-term prognosis in patients with MS who have had acute ST elevation myocardial infarction (STEMI) are somewhat contradictory, since different criteria have been used to diagnose MS. The studies mainly used the ATP-III or IDF criteria, but for the diagnosis of MS in studies conducted in Japan, the ATP-III criteria were modified taking into account national recommendations [4,7,10]. In the Uzbek population, for the diagnosis of MS, the criteria for GFCF [1] are used, with the use of which similar studies have not been carried out. In this regard, this study was planned, in which the diagnosis of MS was carried out according to the criteria for GFCF.
References
Abdellatif, A. M. Metabolic syndrome and its impact on cardiovascular complications in patients with acute coronary syndrome / A. M. Abdellatif, T. A. Shishova // Modern problems of science and education. - 2015. - Issue . 1.- S. 1346.
Andreev, V. V. The nature of atherosclerotic lesions of the aortoarterial bed in metabolic syndrome / V. V. Andreev / / Preventive and clinical medicine. - 2011. - Issue. 3.- S. 64-65.
Boulon C, Lafitte M, Richeboeuf V, Paviot B, Pradeau V, Coste P, Bonnet J, Couffinhal T. Prevalence of metabolic syndrome after acute coronary syndrome and its prognostic signifcance. Am J Cardiol, 2006;98:1429–34
Nakatani D, Sakata Y, Sato H, Mizuno H, Shimizu M, Suna S, Ito H, Koretsune Y, Hirayama A, Hori M; Osaka Acute Coronary Insufficiency Study (OACIS) Group. Clinical Impact of Metabolic Syndrome and Its Additive Effect With Smoking on Subsequent Cardiac Events After Acute Myocardial Infarction. Am J Cardiol 2017;99:885–9
Zeller, M. Prevalence and Impact of Metabolic Syndrome on Hospital Outcomes in Acute Myocardial Infarction/ M. Zeller [et al.]// Arch. Intern. Med.- 2005.- Vol. 165.- P. 1192-1198.
Gromnatsky, N. I. Features of heart damage in metabolic syndrome in young and middle-aged patients / N. I. Gromnatsky, G. D. Petrova / / Russian Journal of Cardiology. - 2007. - Issue. 5.- S. 24-27. 49. 7. Diagnostic evaluation of the functional activity of the vascular endothelium in metabolic syndrome and coronary heart disease /V. A. Nevzorova [et al.] // Cardiovascular therapy and prevention. - 2011. - V. 10. No. 2. - P. 81-87.
Young JB, Abraham WT, Smith AL et al. Combined cardiac resynchroniza-4.
tion and implantable cardioversion defibrillation in advanced chronic heart
failure: the MIRACLE ICD Trial. JAMA. 2003;289(20):2685–2694.
Uchida Y, Ichimiya S, Ishii H, Kanashiro M, Watanabe J, Yoshikawa D, Takeshita K, Sakai S, Amano T, Matsubara T, Murohara T. Impact of Metabolic Syndrome on Various Aspects of Microcirculation and Major Adverse Cardiac Events in Patients With ST-Segment Elevation Myocardial Infarction. Circ J, 2022;76:1972–9
Aloyevna G. T., Turdikhadjayevna B. K. Bronchial Asthma in Children and Covid-19: Features of the Course of Comorbidity //Galaxy International Interdisciplinary Research Journal. – 2022. – Т. 10. – №. 5. – С. 202-205.
